Literature DB >> 10100992

Expression of cathepsin K in lung epithelial cells.

F Bühling1, A Gerber, C Häckel, S Krüger, T Köhnlein, D Brömme, D Reinhold, S Ansorge, T Welte.   

Abstract

Alveolar and bronchial epithelial cells have been shown to have regulatory functions in the maintenance of lung structure and function. Recent evidence supports the premise that these cells can synthesize a variety of extracellular matrix components in vitro, suggesting an active participation in connective tissue remodeling. Their possible role in extracellular matrix degradation, however, is less clear. This study addresses the question of whether alveolar and bronchial epithelial cells express the highly collagenolytic and elastinolytic cysteine proteinase cathepsin K, which has recently been newly described. We provide evidence that the epithelial cell lines A549 and BEAS-2B are capable of expressing cathepsin K messenger RNA. Furthermore, we show that cathepsin K is expressed in normal bronchial epithelial cells. Western blot analyses of human lung-tissue lysates revealed specific immunoreactivity at molecular weights of 46 and 27 kD, corresponding to the procathepsin and the mature cathepsin K. Immunohistochemical analyses showed a pronounced staining of bronchial epithelial cells and in single alveolar epithelial cells. Using a specific fluorogenic cytochemical assay, the intracellular activity of the enzyme was localized. These findings demonstrate that bronchial and alveolar epithelial cells are capable of expressing cathepsin K, which could be of considerable importance for remodeling processes of the extracellular matrix in the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100992     DOI: 10.1165/ajrcmb.20.4.3405

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  28 in total

1.  A putative role for cathepsin K in degradation of AA and AL amyloidosis.

Authors:  C Röcken; B Stix; D Brömme; S Ansorge; A Roessner; F Bühling
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 2.  New treatment modalities in osteoporosis.

Authors:  Ernesto Canalis
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

3.  Photoactivated inhibition of cathepsin K in a 3D tumor model.

Authors:  Mackenzie K Herroon; Rajgopal Sharma; Erandi Rajagurubandara; Claudia Turro; Jeremy J Kodanko; Izabela Podgorski
Journal:  Biol Chem       Date:  2016-06-01       Impact factor: 3.915

4.  Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis.

Authors:  Tara Sabo-Attwood; Maria Ramos-Nino; Jeffrey Bond; Kelly J Butnor; Nicholas Heintz; Achim D Gruber; Chad Steele; Douglas J Taatjes; Pamela Vacek; Brooke T Mossman
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C.

Authors:  Mariana Kasabova; Alix Joulin-Giet; Fabien Lecaille; Brendan F Gilmore; Sylvain Marchand-Adam; Ahlame Saidi; Gilles Lalmanach
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

7.  Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia.

Authors:  Ozden Altiok; Ryuji Yasumatsu; Gulbin Bingol-Karakoc; Richard J Riese; Mildred T Stahlman; William Dwyer; Richard A Pierce; Dieter Bromme; Ekkehard Weber; Sule Cataltepe
Journal:  Am J Respir Crit Care Med       Date:  2005-09-15       Impact factor: 21.405

8.  S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.

Authors:  Marcio F M Alves; Luciano Puzer; Simone S Cotrin; Maria Aparecida Juliano; Luiz Juliano; Dieter Brömme; Adriana K Carmona
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

Review 10.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.